CACHEXIA; CANCER
Clinical trials for CACHEXIA; CANCER explained in plain language.
Never miss a new study
Get alerted when new CACHEXIA; CANCER trials appear
Sign up with your email to follow new studies for CACHEXIA; CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut health breakthrough: postbiotic may fight cancer wasting
Symptom relief Not yet recruitingThis study tests whether an oral postbiotic supplement called JK-5G can help people with advanced non-small-cell lung cancer who are experiencing cachexia—a condition causing severe weight loss and muscle wasting. About 150 participants will receive either JK-5G or a placebo for …
Matched conditions: CACHEXIA; CANCER
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Symptom relief
Last updated May 17, 2026 04:38 UTC
-
Poop pills for cancer wasting? new trial tests gut bacteria fix
Symptom relief Not yet recruitingThis study tests whether transplanting healthy gut bacteria (fecal microbiota transplantation) can help advanced cancer patients who are losing weight and appetite. About 66 adults with stomach, colorectal, or lung cancer will receive the treatment. The goal is to see if it impro…
Matched conditions: CACHEXIA; CANCER
Phase: PHASE2 • Sponsor: Hua Jiang • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
New shot aims to reverse wasting in cancer patients
Symptom relief Not yet recruitingThis early-stage study tests an experimental drug called GB18 in cancer patients who are losing weight and muscle (cachexia). The drug is designed to improve appetite and stop weight loss by blocking a specific protein. About 18 to 36 adults with advanced solid tumors will receiv…
Matched conditions: CACHEXIA; CANCER
Phase: PHASE1 • Sponsor: Kexing Biopharm Co., Ltd. • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
New drug aims to reverse Cancer-Related wasting
Symptom relief Not yet recruitingThis study tests a new drug called ASCA101 for cachexia, a condition where people with cancer lose weight and muscle. About 135 adults with certain solid tumors will receive ASCA101, an active control, or a placebo for 12 weeks. The main goal is to see if the drug helps increase …
Matched conditions: CACHEXIA; CANCER
Phase: PHASE2 • Sponsor: MetaFines • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC